QuantifiCare, a global leader in imaging solutions, announces a a significant first-instance decision before the Unified Patent Court (UPC), Düsseldorf Local Division. In its decision of April 23, 2026, the UPC ruled in favor of QuantifiCare in its infringement...
A New Spin-Off Dedicated to Aesthetics, While Strengthening Its Core Clinical Trial Imaging January 1, 2026 Sophia Antipolis, France – QuantifiCare, a global leader in 2D/3D imaging solutions for clinical trials, is thrilled to announce the launch of Quartier...
The strategic partnership combines QuantifiCare’s world-leading imaging expertise with Legit.Health’s leading AI to speed up the development of new therapies in dermatology. Biot, France and Bilbao, Spain – 08/28/2025 – In a major step forward for dermatology...
April 23, 2025 Major Legal Victory for QuantifiCare: Düsseldorf Court Confirms Patent Infringement by Canfield’s Vectra H2 System. QuantifiCare, a global leader in imaging solutions, has achieved a significant legal victory in its ongoing effort to defend its...
Monaco, March 27, 2025 – QuantifiCare is proud to announce that the new DermaViz UV has been awarded the prestigious Best Aesthetic Device award in 2025, marking our 6th distinction in 10 years of innovation. This year, among more than 1,000 applications, 220...
QuantifiCare is excited to strengthen its collaboration with Nikon, a world leader in imaging and photography technology. For over 15 years, we have built innovative 2D and 3D camera solutions, including the groundbreaking 3D LifeViz system, on the trusted...